 | • レポートコード：MRC2-11QY05808 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医療用医薬品のグローバル市場について調査・分析したレポートです。種類別（脂質調節剤、麻薬性鎮痛剤、ACE阻害剤、呼吸器剤、利尿剤、カルシウム拮抗薬、ホルモン避妊薬、その他）市場規模、用途別（病院・診療所、製薬企業、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療用医薬品の競争状況、市場シェア ・世界の医療用医薬品市場：種類別市場規模 2015年-2020年（脂質調節剤、麻薬性鎮痛剤、ACE阻害剤、呼吸器剤、利尿剤、カルシウム拮抗薬、ホルモン避妊薬、その他） ・世界の医療用医薬品市場：種類別市場規模予測 2021年-2026年（脂質調節剤、麻薬性鎮痛剤、ACE阻害剤、呼吸器剤、利尿剤、カルシウム拮抗薬、ホルモン避妊薬、その他） ・世界の医療用医薬品市場：用途別市場規模 2015年-2020年（病院・診療所、製薬企業、その他） ・世界の医療用医薬品市場：用途別市場規模予測 2021年-2026年（病院・診療所、製薬企業、その他） ・北米の医療用医薬品市場分析：米国、カナダ ・ヨーロッパの医療用医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療用医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療用医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療用医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceutical Industries、GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer、Sanofi、Merck、AstraZeneca、Bristol-Myers Squibb、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ethical pharmaceuticals also known as prescription drugs are the classes of drugs which can only be sold by a pharmacist when authorised by a written prescription from a medical practitioner.
Globally, North America dominated the market for ethical pharmaceuticals in 2015 due to a large population base suffering from life style related health issues, developed medical infrastructure, high health issue awareness and easy access of practitioners.
Market Analysis and Insights: Global Ethical Pharmaceuticals Market
The global Ethical Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ethical Pharmaceuticals Scope and Market Size
Ethical Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ethical Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ethical Pharmaceuticals market is segmented into
Lipid Regulators
Narcotic Analgesics
ACE Inhibitors
Respiratory Agents
Diuretics
Calcium Antagonists
Hormonal Contraceptives
Others
Segment by Application, the Ethical Pharmaceuticals market is segmented into
Hospitals and Clinics
Pharmaceutical Company
Others
Regional and Country-level Analysis
The Ethical Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ethical Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ethical Pharmaceuticals Market Share Analysis
Ethical Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ethical Pharmaceuticals business, the date to enter into the Ethical Pharmaceuticals market, Ethical Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Teva Pharmaceutical Industries
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Sanofi
Merck
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
1 Study Coverage
1.1 Ethical Pharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Ethical Pharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ethical Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Lipid Regulators
1.4.3 Narcotic Analgesics
1.4.4 ACE Inhibitors
1.4.5 Respiratory Agents
1.4.6 Diuretics
1.4.7 Calcium Antagonists
1.4.8 Hormonal Contraceptives
1.4.9 Others
1.5 Market by Application
1.5.1 Global Ethical Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Hospitals and Clinics
1.5.3 Pharmaceutical Company
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ethical Pharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Ethical Pharmaceuticals Revenue 2015-2026
2.1.2 Global Ethical Pharmaceuticals Sales 2015-2026
2.2 Global Ethical Pharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ethical Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ethical Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ethical Pharmaceuticals Competitor Landscape by Players
3.1 Ethical Pharmaceuticals Sales by Manufacturers
3.1.1 Ethical Pharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Ethical Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Ethical Pharmaceuticals Revenue by Manufacturers
3.2.1 Ethical Pharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Ethical Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ethical Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ethical Pharmaceuticals Revenue in 2019
3.2.5 Global Ethical Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ethical Pharmaceuticals Price by Manufacturers
3.4 Ethical Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Ethical Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ethical Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Ethical Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ethical Pharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Ethical Pharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Ethical Pharmaceuticals Revenue by Type (2015-2020)
4.1.3 Ethical Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ethical Pharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Ethical Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Ethical Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Ethical Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ethical Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ethical Pharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Ethical Pharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Ethical Pharmaceuticals Revenue by Application (2015-2020)
5.1.3 Ethical Pharmaceuticals Price by Application (2015-2020)
5.2 Ethical Pharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Ethical Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Ethical Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Ethical Pharmaceuticals Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ethical Pharmaceuticals by Country
6.1.1 North America Ethical Pharmaceuticals Sales by Country
6.1.2 North America Ethical Pharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ethical Pharmaceuticals Market Facts & Figures by Type
6.3 North America Ethical Pharmaceuticals Market Facts & Figures by Application
7 Europe
7.1 Europe Ethical Pharmaceuticals by Country
7.1.1 Europe Ethical Pharmaceuticals Sales by Country
7.1.2 Europe Ethical Pharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ethical Pharmaceuticals Market Facts & Figures by Type
7.3 Europe Ethical Pharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ethical Pharmaceuticals by Region
8.1.1 Asia Pacific Ethical Pharmaceuticals Sales by Region
8.1.2 Asia Pacific Ethical Pharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ethical Pharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Ethical Pharmaceuticals Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ethical Pharmaceuticals by Country
9.1.1 Latin America Ethical Pharmaceuticals Sales by Country
9.1.2 Latin America Ethical Pharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ethical Pharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Ethical Pharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ethical Pharmaceuticals by Country
10.1.1 Middle East and Africa Ethical Pharmaceuticals Sales by Country
10.1.2 Middle East and Africa Ethical Pharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ethical Pharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Ethical Pharmaceuticals Market Facts & Figures by Application
11 Company Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Corporation Information
11.1.2 Teva Pharmaceutical Industries Description and Business Overview
11.1.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Ethical Pharmaceuticals Products Offered
11.1.5 Teva Pharmaceutical Industries Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Ethical Pharmaceuticals Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Ethical Pharmaceuticals Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Ethical Pharmaceuticals Products Offered
11.4.5 Novartis Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Ethical Pharmaceuticals Products Offered
11.5.5 Pfizer Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Ethical Pharmaceuticals Products Offered
11.6.5 Sanofi Related Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description and Business Overview
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Ethical Pharmaceuticals Products Offered
11.7.5 Merck Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Ethical Pharmaceuticals Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Corporation Information
11.9.2 Bristol-Myers Squibb Description and Business Overview
11.9.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol-Myers Squibb Ethical Pharmaceuticals Products Offered
11.9.5 Bristol-Myers Squibb Related Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Description and Business Overview
11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eli Lilly Ethical Pharmaceuticals Products Offered
11.10.5 Eli Lilly Related Developments
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Corporation Information
11.1.2 Teva Pharmaceutical Industries Description and Business Overview
11.1.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Ethical Pharmaceuticals Products Offered
11.1.5 Teva Pharmaceutical Industries Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ethical Pharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Ethical Pharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Ethical Pharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Ethical Pharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Ethical Pharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Ethical Pharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Ethical Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Ethical Pharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Ethical Pharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Ethical Pharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Ethical Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ethical Pharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ethical Pharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ethical Pharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ethical Pharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Ethical Pharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Ethical Pharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Ethical Pharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Ethical Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ethical Pharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ethical Pharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ethical Pharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ethical Pharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ethical Pharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ethical Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ethical Pharmaceuticals Market Segments
Table 2. Ranking of Global Top Ethical Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ethical Pharmaceuticals Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Lipid Regulators
Table 5. Major Manufacturers of Narcotic Analgesics
Table 6. Major Manufacturers of ACE Inhibitors
Table 7. Major Manufacturers of Respiratory Agents
Table 8. Major Manufacturers of Diuretics
Table 9. Major Manufacturers of Calcium Antagonists
Table 10. Major Manufacturers of Hormonal Contraceptives
Table 11. Major Manufacturers of Others
Table 12. Global Ethical Pharmaceuticals Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Ethical Pharmaceuticals Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Ethical Pharmaceuticals Sales by Regions 2015-2020 (K MT)
Table 15. Global Ethical Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 16. Global Ethical Pharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Ethical Pharmaceuticals Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Ethical Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 19. Global Ethical Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Ethical Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ethical Pharmaceuticals as of 2019)
Table 21. Ethical Pharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Ethical Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Ethical Pharmaceuticals Price (2015-2020) (USD/MT)
Table 24. Ethical Pharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Ethical Pharmaceuticals Product Type
Table 26. Date of International Manufacturers Enter into Ethical Pharmaceuticals Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Ethical Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 29. Global Ethical Pharmaceuticals Sales Share by Type (2015-2020)
Table 30. Global Ethical Pharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Ethical Pharmaceuticals Revenue Share by Type (2015-2020)
Table 32. Ethical Pharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Ethical Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 34. Global Ethical Pharmaceuticals Sales Share by Application (2015-2020)
Table 35. North America Ethical Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 36. North America Ethical Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 37. North America Ethical Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Ethical Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 39. North America Ethical Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 40. North America Ethical Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 41. North America Ethical Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 42. North America Ethical Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 43. Europe Ethical Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 44. Europe Ethical Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 45. Europe Ethical Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Ethical Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 47. Europe Ethical Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 48. Europe Ethical Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 49. Europe Ethical Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 50. Europe Ethical Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Ethical Pharmaceuticals Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Ethical Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Ethical Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Ethical Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Ethical Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Ethical Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Ethical Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Ethical Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 59. Latin America Ethical Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 60. Latin America Ethical Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Ethical Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Ethical Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 63. Latin America Ethical Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 64. Latin America Ethical Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 65. Latin America Ethical Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 66. Latin America Ethical Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Ethical Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Ethical Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Ethical Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Ethical Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Ethical Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Ethical Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Ethical Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Ethical Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 75. Teva Pharmaceutical Industries Corporation Information
Table 76. Teva Pharmaceutical Industries Description and Major Businesses
Table 77. Teva Pharmaceutical Industries Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Teva Pharmaceutical Industries Product
Table 79. Teva Pharmaceutical Industries Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Major Businesses
Table 82. GlaxoSmithKline Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. AstraZeneca Product
Table 114. AstraZeneca Recent Development
Table 115. Bristol-Myers Squibb Corporation Information
Table 116. Bristol-Myers Squibb Description and Major Businesses
Table 117. Bristol-Myers Squibb Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Bristol-Myers Squibb Product
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly Ethical Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Eli Lilly Product
Table 124. Eli Lilly Recent Development
Table 125. Global Ethical Pharmaceuticals Sales Forecast by Regions (2021-2026) (K MT)
Table 126. Global Ethical Pharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Ethical Pharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Ethical Pharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Ethical Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 130. North America: Ethical Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Ethical Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 132. Europe: Ethical Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Ethical Pharmaceuticals Sales Forecast by Region (2021-2026) (K MT)
Table 134. Asia Pacific: Ethical Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Ethical Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 136. Latin America: Ethical Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Ethical Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 138. Middle East and Africa: Ethical Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Ethical Pharmaceuticals Players
Table 143. Ethical Pharmaceuticals Customers List
Table 144. Ethical Pharmaceuticals Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Ethical Pharmaceuticals Product Picture
Figure 2. Global Ethical Pharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Lipid Regulators Product Picture
Figure 4. Narcotic Analgesics Product Picture
Figure 5. ACE Inhibitors Product Picture
Figure 6. Respiratory Agents Product Picture
Figure 7. Diuretics Product Picture
Figure 8. Calcium Antagonists Product Picture
Figure 9. Hormonal Contraceptives Product Picture
Figure 10. Others Product Picture
Figure 11. Global Ethical Pharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 12. Hospitals and Clinics
Figure 13. Pharmaceutical Company
Figure 14. Others
Figure 15. Ethical Pharmaceuticals Report Years Considered
Figure 16. Global Ethical Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 17. Global Ethical Pharmaceuticals Sales 2015-2026 (K MT)
Figure 18. Global Ethical Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Ethical Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 20. Global Ethical Pharmaceuticals Sales Market Share by Region in 2019
Figure 21. Global Ethical Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 22. Global Ethical Pharmaceuticals Revenue Market Share by Region in 2019
Figure 23. Global Ethical Pharmaceuticals Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Ethical Pharmaceuticals Revenue in 2019
Figure 25. Ethical Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Ethical Pharmaceuticals Sales Market Share by Type (2015-2020)
Figure 27. Global Ethical Pharmaceuticals Sales Market Share by Type in 2019
Figure 28. Global Ethical Pharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 29. Global Ethical Pharmaceuticals Revenue Market Share by Type in 2019
Figure 30. Global Ethical Pharmaceuticals Market Share by Price Range (2015-2020)
Figure 31. Global Ethical Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 32. Global Ethical Pharmaceuticals Sales Market Share by Application in 2019
Figure 33. Global Ethical Pharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 34. Global Ethical Pharmaceuticals Revenue Market Share by Application in 2019
Figure 35. North America Ethical Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 36. North America Ethical Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Ethical Pharmaceuticals Sales Market Share by Country in 2019
Figure 38. North America Ethical Pharmaceuticals Revenue Market Share by Country in 2019
Figure 39. U.S. Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.S. Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 42. Canada Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Ethical Pharmaceuticals Market Share by Type in 2019
Figure 44. North America Ethical Pharmaceuticals Market Share by Application in 2019
Figure 45. Europe Ethical Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Ethical Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Ethical Pharmaceuticals Sales Market Share by Country in 2019
Figure 48. Europe Ethical Pharmaceuticals Revenue Market Share by Country in 2019
Figure 49. Germany Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Ethical Pharmaceuticals Market Share by Type in 2019
Figure 60. Europe Ethical Pharmaceuticals Market Share by Application in 2019
Figure 61. Asia Pacific Ethical Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific Ethical Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Ethical Pharmaceuticals Sales Market Share by Region in 2019
Figure 64. Asia Pacific Ethical Pharmaceuticals Revenue Market Share by Region in 2019
Figure 65. China Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 66. China Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 72. India Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Ethical Pharmaceuticals Market Share by Type in 2019
Figure 88. Asia Pacific Ethical Pharmaceuticals Market Share by Application in 2019
Figure 89. Latin America Ethical Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Ethical Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Ethical Pharmaceuticals Sales Market Share by Country in 2019
Figure 92. Latin America Ethical Pharmaceuticals Revenue Market Share by Country in 2019
Figure 93. Mexico Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Ethical Pharmaceuticals Market Share by Type in 2019
Figure 100. Latin America Ethical Pharmaceuticals Market Share by Application in 2019
Figure 101. Middle East and Africa Ethical Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 102. Middle East and Africa Ethical Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Ethical Pharmaceuticals Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Ethical Pharmaceuticals Revenue Market Share by Country in 2019
Figure 105. Turkey Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 106. Turkey Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 108. Saudi Arabia Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Ethical Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 110. U.A.E Ethical Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Ethical Pharmaceuticals Market Share by Type in 2019
Figure 112. Middle East and Africa Ethical Pharmaceuticals Market Share by Application in 2019
Figure 113. North America Ethical Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Ethical Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Ethical Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Ethical Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Ethical Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Ethical Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Ethical Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Ethical Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Ethical Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Ethical Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
エシカルファッションの世界市場（～2026年） Ethical fashion is about designing and manufacturing clothes that care for people and communities while minimizing the impact on the environment. It focuses on both the social and environmental impact of fashion, and to improve the working conditions of laborers. Market Analysis and Insights: Global…- 脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
- セキュリティエンベロープの世界市場（～2026年） Security Envelope is ideal for all business, professional and personal correspondence. Keep prying eyes off your important documents. Market Analysis and Insights: Global Security Envelopes Market The global Security Envelopes market size is projected to reach US$ XX million by 2026, from US$ XX mil…
- カメリナオイルの世界市場（～2026年） Market Analysis and Insights: Global Camelina Oil Market The global Camelina Oil market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Camelina Oil Scope and Market Size Camelina Oil market is segmented by Type, and by Appli…
- ハラールヘアケアの世界市場（～2026年） Market Analysis and Insights: Global Halal Hair Care Market The global Halal Hair Care market size is projected to reach US$ 539.1 million by 2026, from US$ 504.5 million in 2020, at a CAGR of 6.4%% during 2021-2026. Global Halal Hair Care Scope and Market Size Halal Hair Care market is segmented by…